B

bluebird bio

D
BLUE
USD
-0.0615
(-14.0764%)
Market Closed
151,686.00
Volume
-1.64
EPS
-
Div Yield
-0.163217
P/E
72,795,159.81
Market Cap
Today
-16.2614%
1 Week
-19.112%
1 Month
-27.877%
6 Months
-63.196%
12 Months
-89.365%
Year To Date
-72.797%
All Time
-98.887%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
I
ICPT
(%)
USD
S
SRPT
-2.57
(-2.0903%)
USD
B
BHVN
-0.645
(-1.2013%)
USD
B
BPMC
1.79
(1.7956%)
USD
R
RARE
-0.1
(-0.1979%)
USD
X
XLRN
(%)
USD
A
AKRO
2.165
(6.6167%)
USD
M
MRTX
(%)
USD

Title:
bluebird bio

Sector:
Healthcare
Industry:
Biotechnology
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
Do you need help or have a question?
Contact Us